| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |